• to reduce the potential risk of severe cardiovascular (coronary heart and blood vessel) challenges in Older people with variety 2 diabetes and heart problemsWegovy® includes semaglutide and should not be utilised with other semaglutide-made up of goods or other GLP-1 receptor agonist medicines.$100 billion. That’s the amount the weight loss